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o see one of our own at the
helm of a major university is
unquestionably inspirational.
And for those of us with two X
chromosomes, perhaps even more so. I
tried to imagine myself in the role of
laboratory Cinderella: plucked from
the work-a-day world of robocyclers
and biohazard waste to a realm of
literati, artists, and trustees, gliding
into, if not glass slippers, pantyhose
and pumps and a far spifﬁer wardrobe,
my voice transformed from the
constrained format of a journal article
to one that can carry sway in every
aspect of our culture.
This transition must have been
second nature to Shirley Tilghman,
President of Princeton University (see
Video S1). She is the model of grace,
intellect, perseverance, womanhood,
and tact. Just 24 hours before my
interview with her was scheduled,
Lawrence Summers (President of
Harvard) had resigned, and I half
anticipated that I might be bumped for
a sound bite. Indeed, her phone was
ringing off the hook, but our interview
held fast.
I had driven to New Jersey from my
father’s house in Pennsylvania the night
before. As I turned north on Highway
206, I took in the Lawrenceville playing
ﬁelds on the right and the stately old
homes on the left, recalling a day 36
years ago when I followed the Orange
Key Tour, the last time I had visited
Princeton. I recognized Nassau Hall,
the pair of bronze tigers protecting a
set of massive, deep-blue doors
embedded in ivy-covered stone walls. I
approached the old building, walked
across the marble foyer to an
unmarked door, and fell into a cozy
warren, made even more inviting by
soft green colors and a bowl of
chocolates.
Shirley met me and led me down a
little set of steps to her ofﬁce. Journal
covers prominently displayed near her
desk remind her of her former life, as
does a bronzed Rainin pipetman with a
plaque that reads ‘‘I’m a genius!’’, given
to her by her lab when she became
president. I told her the topics I wanted
to cover in our interview.
Jane Gitschier: ...and third, I want to
talk about Princeton!
Shirley Tilghman: Yeah!
JG: So why don’t we start with that? I
have read a couple of interviews with
you, and I was so impressed by your
comments about how you just love the
institution. You’ve been here for almost
20 years and president for almost ﬁve.
Tell me, why do you love it here?
ST: There are really two answers. First,
it’s a place that is always striving for
excellence, and excellence with
integrity. I’ve loved that since the day I
arrived.
The second is that it is a place that is
run by the faculty. Here I am, as
testimony to that! In fact, if you look at
the history of the university, there has
been only one president in recent
history that did not come from the
faculty. It is a place that respects
scholarship, respects intellectuals, and
believes that a university is best run by
people who grew up caring about the
life of the mind.
JG: That’s wonderful!
ST: Yes, and the third thing I love about
Princeton is that the students are just
spectacular. They challenge you and
make you better. Interacting with them
in my old life in the lab and in my new
life in Nassau Hall, every day is just fun.
JG: How many students are there?
ST: There are now about 4,700
undergraduates and we’re going up to
5,100. We’re in a process of expansion,
as a matter of fact.
JG: Why do you feel the need to
increase the undergraduate
population?
ST: There were a number of reasons,
but probably the most important was
that during the last 30 years, we had
kept the population of the
undergraduate student body relatively
constant, while we were growing the
faculty at a rate of about 1% per year.
And we had reached a point where the
student-faculty ratio was under six,
which is extraordinary for a university,
particularly a research university.
Second, we have the largest
endowment per student in the country.
I think that is a joy, to a president, but
it also creates a responsibility. I believe
that the trustees, who ultimately made
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we have the capacity in both faculty
and resources to educate more
students, we should.
JG: And the graduate student body?
ST: We have about 2,100 graduate
students. The graduate school student
population has always been roughly a
third the size of the undergraduate
student body. We can do that because,
of course, we have very few professional
schools.
JG: Do you think that there would be
some virtue to having a law school or a
medical school afﬁliated with the
university,oristhatjustnotbroughtup?
ST: It comes up with a periodicity of
about 25 years.
JG: Pretty slow!
ST: But it is studied periodically. The
trustees cogitate about it, and, at the
end, they decide that one of our
distinctive characters is that we are, as
an institution, so focused on two things:
(1) the best quality undergraduate
education that we can deliver, and (2)
really stellar PhD production. The fact
that we’re so focused is one of our
strengths.
JG: I read one account of how you had
been on the search committee [for the
president] and then, while you went off
to teach a class, the other members
decided to offer you the job!
ST: It was more, ‘‘Shouldn’t we think
about the possibility that she might be
a candidate?’’ They were still six weeks
away from making their ﬁnal decision,
but that is roughly how it happened.
JG: I’m thinking of how weird this is, to
go from being a professor with almost
no administrative experience....
ST: What were they thinking?!!
JG: What do you think they saw in you?
Did you have a vision that you
articulated to them?
ST: The search committee met a lot for
the ﬁrst four months. We spent a lot of
time talking about the presidency and
about Princeton. We traveled together,
in pairs, all over the country
interviewing other presidents, leaders
in the scientiﬁc community, and those
who would have perspectives on what a
university is going to face in science.
So this group really knew each other
well by the time they asked me to step
down [from the committee]; we had all
been very frank with one another. This
process was highly conﬁdential, so
people felt free to express their views. I
suspect that by the time they asked me
to step off the committee, they had a
pretty good idea of how I thought
about Princeton, what the challenges
were likely to be, what I thought we
should be looking for in a candidate. I
had supported some of the candidates
who were clearly rising to the short list,
so I think they also had a sense of my
taste.
JG: At the time, what did you think
were the challenges, opportunities, and
future directions for Princeton?
ST: Certainly, at the time I felt strongly
that it would be helpful to have
someone who could grapple with some
of the challenges that research
universities face—to sustain what I
think is our critical role as innovation
engines for the country. And as we look
at what has happened in Washington
over the last four years, I think this
concern has been borne out—despite
what we heard in the State of the Union
address—‘‘Show me the money!’’ I was
worried that as science became more
expensive and more complicated, how
could we continue to provide support
in universities? After all, there is
nothing sacrosanct about the idea that
fundamental research must occur in
universities. It could have easily been
decided in the late ’40s that federally
funded research should occur in
research institutes or in national labs. I
think, though, the connection between
science and teaching has been so
productive for this country.
The other thing that I was concerned
about on the search committee was
how a place like Princeton, which has
both the joy and the burden of great
tradition, balance respect for that
tradition with the need to move
forward.
JG: So, how do you like your job?
ST: I love my job!
JG: What do you love about it?
ST: Well, it goes back to your very ﬁrst
question. I love this place. You can
effect change in real time. You can see
the effect of what you’re doing, from
recruiting a senior faculty member
down to simple things like hearing
about some ridiculous rule and
changing it to make everybody’s life
easier.
JG: Power has its merits.
ST: You have to be careful, of course,
because you don’t want to become a
rogue elephant.
Another reason that this is such a
great job, which I didn’t fully
anticipate, is the opportunities it has
given me to broaden my intellectual
horizons. For example, I was in New
York City yesterday talking to the
Commissioner of Cultural Affairs
about how our new arts initiative can
engage New York City more effectively.
This is an area of the university world
that I knew very little about until I
became president.
JG: Do you ever feel overwhelmed by all
the different tasks you need to attend
to, or is it manageable?
ST: It’s manageable, because Princeton
is so focused on trying to be very good
at a small number of things.
JG: You are still in the molecular
biology department?
ST: As far as I know! They haven’t
disowned me yet.
JG: You don’t teach any more, do you?
ST: I do teach! I teach part of the
introductory molecular biology class to
freshman and sophomore students.
And I advise senior theses and junior
independent work.
JG: So, you still have a laboratory!
ST: I just sent off my last paper to Genes
and Development, which I hope will
publish it. My last post-doc is about to
leave, and then I’ll close the lab down.
As you can imagine, it is not possible
to run a lab and run this university at
the same time. That was one of the clear
implications of agreeing to do this [job].
JG: When I’ve told other women I am
about to interview you, they say
something to the effect of ‘‘Oh, she’s
my role model—have you heard ‘The
Speech’?’’ I’ve never had the beneﬁt of
hearing you speak about women in
science. Perhaps you could condense it
into a few minutes of tape! Or perhaps
I can ask a few questions and maybe the
speech will come out.
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JG: OK, let’s start then with your early
career. You were an assistant professor
at Temple [University] and then at Fox
Chase [Cancer Center] in Philadelphia.
Were you then looking at Princeton
because of the proximity?
ST: No, I began to think about leaving
Fox Chase when David Baltimore tried
to recruit me to the Whitehead
[Institute], and I looked at it very
seriously. I saw a great deal that I found
enormously attractive, including the
chance to be with Rudi Jaenisch, who is
in my ﬁeld and whom I adore. It was
after it became known that I was
looking that Arnie Levine called and
asked if I would also look at Princeton.
At the end of the day, it was really a
family decision to come to Princeton. I
was single by this point, with two little
kids. As I tried to ﬁgure out how I could
afford to live in Boston, send the
children to private school, commute to
the Massachusetts Institute of
Technology (MIT), it just didn’t
compute. Princeton made everything
possible—a little town with really good
public schools, everything was within
three minutes: three minutes to home,
three minutes to the pediatrician, three
minutes to the primary school, the
nursery school. And it was a great
university.
JG: How did you manage? Your
children were little.
ST: They were age four and six years.
JG: Did you have someone live in your
home?
ST: No, because it wasn’t big enough.
Over the years, I had a whole series of
solutions to the problem you are
identifying. If I had to do it again, I
would deﬁnitely hire a live-in person.
When I look back on the past, I think it
was a terrible mistake not to do it.
JG: I’m sympathetic to your history
because I am also a single parent. We
make these decisions so that we can
function.
ST: It’s really true. If I had been making
that decision purely on the quality and
critical mass of science, I would have
gone to MIT. You do what you have to
do. And I’ve never regretted it for one
minute. Princeton was exactly the right
place for me at that time. And this has
proven to be the right place for me in
the long run, too!
JG: Have we started to touch on ‘‘The
Speech’’? Are we getting close??
ST: One version of ‘‘The Speech’’ is on
the Princeton President’s Web site
(http://www.princeton.edu/president/
speeches). The one that comes closest
to what people are talking about is the
one I gave at Columbia [University] last
year about this time [March 24, 2005].
JG: What was the topic?
ST: It was about the future prospects
for women in science—why it’s
important that women are represented
in science, why it hasn’t happened until
now, and what we need to do to change
things.
JG: One thing that I’ve found incredibly
helpful has been to have Howard
Hughes Medical Institute (HHMI)
funding.
ST: Yes, HHMI was tremendously good
to me. I wouldn’t be studying genomic
imprinting if it hadn’t been for its
support.
JG: And why is that?
ST: I was studying this H19 gene, and
everyone thought I was completely
crazy. If I had had to write an National
Institutes of Health (NIH) grant to
defend it in 1985, I probably would
have had a really hard time. The HHMI
money, as you well know, allows you to
work on whatever you want to work on.
JG: Since you brought it up, how did
you get interested in H19?
ST: Because it was a mystery!
JG: It was so different from what you
had been doing previously, working on
alpha-fetoprotein (AFP).
ST: Yes, but there is a connection. My
ﬁrst real foray into pure mouse
genetics was to study two trans-acting
loci that regulated the levels of
postnatal levels of AFP during mouse
development. One recessive mutation
caused a signiﬁcantly elevated level of
AFP mRNA after birth compared to
wild-type strains. The question we
asked was whether this trans-acting
locus, called raf, regulates genes other
than AFP. So we did a 1980s version of
microarray analysis. We looked for
genes whose hepatic expression
declined after birth in a strain-speciﬁc
manner, in a manner parallel to AFP.
H19 came out of that screen.
Remember those little Millipore
ﬁlters that had grids on them and you’d
grow cDNA-containing bacterial
colonies on them and then hybridize
them? Grunstein-Hogness! So that’s
what we did. H19 was the H row, 19th
spot. We had made a liver cDNA
library and we were screening through
them.
H19 was incredibly abundant and we
showed that it was developmentally
regulated, just like AFP. So this
wonderful student, Vassilis Pachnis,
who’s gone on to be very successful at
Mill Hill [MRC National Institute of
Medical Research] in London,
sequenced it, before machines. He kept
hitting stop codons, and I kept saying,
‘‘Vassilus, you’re making sequencing
mistakes. It must have an open reading
frame. There is no precedent for this
for a spliced polyadenylated RNA.’’ So
this poor guy went back and continued
to sequence and ﬁnally persuaded me
that this was a highly abundant, spliced,
capped RNA with no reading frame.
And that was the mystery!
I kept plugging away on it, thinking
there must be something here. Given its
abundance and its tight regulation, this
can’t be a garbage RNA.
JG: Well, I can see why you thought the
NIH wouldn’t fund it, because we are so
entrenched in dogma.
ST: Right. That is might be imprinted
was just a lucky guess in the early ’90s.
It was one of these funny moments in
science where you just have a leap of
faith. You connect things and have a
‘‘eureka’’ moment. When I guessed it
might be imprinted, I asked Marisa
Bartolomei to check it out. It was the
third gene shown to be imprinted, after
insulin-like growth factor 2 and its
binding protein, Igf2r.
JG: Those genes are adjacent.
ST: That’s what got me going. At the
end of the day we knocked out H19 and
there was no phenotype. If I have one
regret about my career, it is that I had
to stop before I ﬁgured out what H19
does!
Unfortunately this little ﬁlter array
name [H19] has stuck on it.
JG: At least it’s not an acronym that
stands for something you can never
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mammalian genes.
ST: Exactly. I always think the ﬂy guys
had it right. Give genes very distinctive
names.
JG: I agree, but as a human geneticist,
when you have to tell parents, ‘‘We’re
sorry but your child has a mutation in
sonic hedgehog,’’ there’s something
that seems weird about that to me. It
sounds so trivial for something that has
such serious import. But the spirit of
the Drosophila people is fabulous!
But let’s go back to your post-doc,
working with Phil Leder.
ST: It was a wonderful time. The NIH
was the biggest sandbox I had ever
played in. At that time, it was so
exciting. There was literally no area of
life sciences that you could become
interested in and not ﬁnd somebody at
the NIH who was knowledgeable. So it
was exciting and intellectually
engaging.
And Phil was heaven to work for. He
was very supportive and yet gave me
independence. Cloning the globin
gene, as you can imagine, was so
exciting and then discovering that its
structure was so different [having
intervening sequences] from what
everyone had anticipated was thrilling.
It was one of those ‘‘hairs on the back
of your neck’’ moments when you know
you’ve discovered something
important.
Phil has been a model mentor to me
ever since. There is no turn in my
career at which I haven’t consulted
him—including whether to take this
job—and when he hasn’t offered
assistance, advice, moral support.
JG: You are lucky to have that. Very few
of us do. I think we need something to
change so that women don’t say ‘‘I can’t
do this’’ even before they give it a shot.
Have you been able to affect the work
culture at all?
ST: I’ve increasingly started to worry
that we spend too much time talking
about how difﬁcult science is and not
enough talking about the fact that
despite the difﬁculty—and I would
never say it is not difﬁcult because it is
difﬁcult—women can succeed and
thrive. They can balance successful
science careers and children. Think of
the number of women that we know in
that category.
Too often, I think, our graduate
students and post-docs only hear the
sob stories. They hear that it’s so hard
and impossible. I think if you hear that
long enough, you inevitably become
discouraged and conclude that you
can’t be so special that you’ll be able to
overcome all these barriers.
JG: Who do you think they are hearing
this from?
ST: I think they are hearing this from
us!
JG: Aha—this is where ‘‘The Speech’’
comes in!
ST: Yes. In the Columbia speech, I
began with a whole series of pictures of
extremely successful women in science
who have had children and are now
luminaries. And I ended with young
women in science, just post post-doc,
heading off to what I think are going to
be the same kind of careers. I tried to
make the point that it’s not that it isn’t
hard. It is hard! It’s hard for women to
be doctors and lawyers. The more I
learn about it, the more I think there is
nothing unique about science that
makes it more difﬁcult for women to
have a career than any other ﬁeld.
It is possible. What we should be
talking about more are the things you
and I were just talking about. What do
you need to have in your life to make it
possible to have a career and a fulﬁlling
life outside the lab? How do you
organize childcare? How do you take
maternity leave and keep the lab
moving along?
Here at Princeton, we just created a
backup [child] care beneﬁt for all
employees and students. You can call
this company at a moment’s notice and
say, ‘‘It’s a snow day tomorrow, I’ve got
to have someone at my house at 8
o’clock in the morning.’’
JG: Oh, that’s great!
ST: Isn’t that great? And it costsUS$4 an
hour. We are subsidizing it. But imagine
the pressure it takes off people!
JG: You must have very little time to
relax now and your evenings must be
booked!
ST: Yes, that’s one thing that has been
very different. It’s the nights, the
dinners, the receptions. On the other
hand, I often end up going to a student
play or a dance recital or a basketball,
lacrosse, or soccer game, and that is
fun! These students come here and they
entertain me! This is true! I don’t ﬁnd
that it is stressful at all.
JG: Of course, your children are grown
up now. And that is hugely different.
ST: Hugely different! I wouldn’t have
taken this job ten years ago. Couldn’t
have done it. Part of it is managing
your limits. I had a little sign above my
phone in the Lewis Thomas Lab that
said ‘‘Just say no!’’ It’s the only thing
I’ve agreed with Nancy Reagan about.
JG: Well, I’m awfully glad you didn’t say
‘‘No’’ to me! &
Supporting Information
Video S1. Interview with Shirley Tilghman
Found at DOI: 10.1371/journal.pgen.
0020082.sv001 (8.6 MB MOV).
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